Figure 3.
Time on study for patients who responded to selinexor treatment. Swimmers plot of time on study for patients achieving PR or better. Patients achieving CR are shown in green and PR in blue. Red lines indicate time at which best response was confirmed. *Indicates first PET-CT scan at cycle 16 confirming CR. Arrows indicate the patient is still on study as of the date of data cutoff. CTCL, cutaneous T-cell lymphoma; FLG3b, follicular lymphoma grade 3b; MCL, mantle cell lymphoma; RT, Richter’s transformation; WC–AE, withdrawal of consent because of AEs; WC-transplant, withdrawal of consent to undergo SCT; X, progressive disease.

Time on study for patients who responded to selinexor treatment. Swimmers plot of time on study for patients achieving PR or better. Patients achieving CR are shown in green and PR in blue. Red lines indicate time at which best response was confirmed. *Indicates first PET-CT scan at cycle 16 confirming CR. Arrows indicate the patient is still on study as of the date of data cutoff. CTCL, cutaneous T-cell lymphoma; FLG3b, follicular lymphoma grade 3b; MCL, mantle cell lymphoma; RT, Richter’s transformation; WC–AE, withdrawal of consent because of AEs; WC-transplant, withdrawal of consent to undergo SCT; X, progressive disease.

Close Modal

or Create an Account

Close Modal
Close Modal